$ASPN News

Aspen Aerogels Begins Staged Restart of East Providence Facility

Aspen Aerogels (ASPN) Price Target Increased by 51.19% to 6.48

Aspen Aerogels, Inc. 2026 Q1 - Results - Earnings Call Presentation

Barclays Maintains Underweight on Aspen Aerogels, Raises Price Target to $4

Aspen Aerogels Q1 Earnings Call Highlights

Aspen Aerogels, Inc. Q1 2026 Earnings Call Summary

Aspen Aerogels (ASPN) Q1 2026 Earnings Transcript

Aspen Aerogels (NYSE:ASPN) Rallies on Strong Cash Position and Above-Consensus Q2 Guidance Despite Slight Earnings Miss and Facility Incident

Aspen Aerogels, Inc. (ASPN) Q1 2026 Earnings Call Transcript

Aspen Aerogels Sees Q2 GAAP EPS $(0.24)-$(0.17) vs $(0.21) Est; Sees Sales $40.000M-$48.000M vs $41.083M Est

Aspen Aerogels Q1 Adj. EPS $(0.28) Misses $(0.26) Estimate, Sales $37.884M Beat $37.388M Estimate

Aspen Aerogels, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call

Aspen Aerogels Provides East Providence Facility Update

Aspen Aerogels Provides Update On Facility In East Providence, RI; Facility Remains Offline And Expects To Provide Further Update In Connection With Q1 2026 Release In May

Aspen Aerogels Provides Update on Incident at East Providence Facility

Aspen Aerogels confirms an incident occurred at East Providence Manufacturing Facility On April 8, Site Is Secure And Under Control; Incident Is Being Investigated

Aspen Aerogels (ASPN) Price Target Decreased by 35.38% to 4.28

Aspen Aerogels, Inc. to Participate in the 38th Annual Roth Conference

Aspen Aerogels price target lowered to $4 from $10 at B. Riley

Aspen Aerogels: A Long Road Ahead